125 related articles for article (PubMed ID: 27816489)
21. Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.
Gallenne T; Ross KN; Visser NL; Salony ; Desmet CJ; Wittner BS; Wessels LFA; Ramaswamy S; Peeper DS
Oncotarget; 2017 Mar; 8(13):20572-20587. PubMed ID: 28411283
[TBL] [Abstract][Full Text] [Related]
22. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
23. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
25. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.
Song Y; Qian L; Song S; Chen L; Zhang Y; Yuan G; Zhang H; Xia Q; Hu M; Yu M; Shi M; Jiang Z; Guo N
Mol Immunol; 2008 Jan; 45(1):137-43. PubMed ID: 17572495
[TBL] [Abstract][Full Text] [Related]
26. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
27. Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
Desmet CJ; Gallenne T; Prieur A; Reyal F; Visser NL; Wittner BS; Smit MA; Geiger TR; Laoukili J; Iskit S; Rodenko B; Zwart W; Evers B; Horlings H; Ajouaou A; Zevenhoven J; van Vliet M; Ramaswamy S; Wessels LF; Peeper DS
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5139-44. PubMed ID: 23483055
[TBL] [Abstract][Full Text] [Related]
28. A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells.
Pakay JL; Diesch J; Gilan O; Yip YY; Sayan E; Kolch W; Mariadason JM; Hannan RD; Tulchinsky E; Dhillon AS
Oncogene; 2012 Apr; 31(14):1817-24. PubMed ID: 21874050
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
30. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
31. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
[TBL] [Abstract][Full Text] [Related]
32. Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival.
Iskit S; Schlicker A; Wessels L; Peeper DS
Oncotarget; 2015 Dec; 6(41):43146-61. PubMed ID: 26646695
[TBL] [Abstract][Full Text] [Related]
33. Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E
Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
[TBL] [Abstract][Full Text] [Related]
34. sp
Gueder N; Allan G; Telliez MS; Hague F; Fernandez JM; Sanchez-Fernandez EM; Ortiz-Mellet C; Ahidouch A; Ouadid-Ahidouch H
J Cell Physiol; 2017 Dec; 232(12):3631-3640. PubMed ID: 28145580
[TBL] [Abstract][Full Text] [Related]
35. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
[TBL] [Abstract][Full Text] [Related]
36. Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells.
Debinski W; Gibo DM
Cancer Biol Ther; 2011 Jan; 11(2):254-62. PubMed ID: 21088499
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
38. Naringenin targets ERK2 and suppresses UVB-induced photoaging.
Jung SK; Ha SJ; Jung CH; Kim YT; Lee HK; Kim MO; Lee MH; Mottamal M; Bode AM; Lee KW; Dong Z
J Cell Mol Med; 2016 May; 20(5):909-19. PubMed ID: 26861188
[TBL] [Abstract][Full Text] [Related]
39. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
Schröder C; Schumacher U; Müller V; Wirtz RM; Streichert T; Richter U; Wicklein D; Milde-Langosch K
Eur J Cancer; 2010 Jun; 46(9):1650-60. PubMed ID: 20226654
[TBL] [Abstract][Full Text] [Related]
40. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Milde-Langosch K; Janke S; Wagner I; Schröder C; Streichert T; Bamberger AM; Jänicke F; Löning T
Breast Cancer Res Treat; 2008 Feb; 107(3):337-47. PubMed ID: 17393299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
